Skip to main content

Eupraxia Pharmaceuticals Inc(EPRX-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Eupraxia Pharmaceuticals Inc up on Thursday (EPRX)

Automated Summaries - The Globe and Mail - Thu Apr 4, 4:02PM CDT

Eupraxia Pharmaceuticals Inc opened trading today at $4.01 and closed at $4.10. prices ranged from $4.01 to $4.45.

Share prices raised 6.49% from the previous day's close of $3.85.

Today across North America, the TSX Composite closed 0.17% at 22112.46, the S&P 500 closed 0.11% at 5211.49, the Dow Jones Industrial Average closed -0.11% at 39127.14 and the Nasdaq Composite closed 0.23% at 16277.46.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

A total of 131,131 shares was traded during the last trading day, with total trades of 178. On average, Eupraxia Pharmaceuticals Inc has traded 71,401 shares over the last 5-days and 54,658 year-to-date.

Trading across the entire TSX saw 1,535 price advancers against 3,670 declines and 135 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.85 (April 03,2024). Moreover, the shares have eased -2.61 percent in the last 12 months, while in 2024, they have decreased -23.65%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $137.15 million on a float of 35,622 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Eupraxia Pharmaceuticals Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe